Tuberculosis Mortality in HIV/AIDS Patients: A Comparative Analysis

Strategic Insights -

The study aimed to investigate the factors contributing to mortality in tuberculosis (TB) patients, particularly in those with Human Immunodeficiency Virus/AIDS (HIV/AIDS). The researchers conducted a retrospective case-control study of patients admitted to hospitals between 1988 and 1993. The analysis revealed distinct differences in the circumstances surrounding death in TB patients with and without HIV/AIDS.

Key Takeaways:

  • Group A (30 patients who died with TB but without HIV/AIDS) consisted predominantly of males between 45 and 49 years old with a history of heavy alcohol abuse, who sought medical attention late and had severe disseminated disease, resulting in over 50% death within 15 days of initiation of therapy.
  • Group C (35 patients with HIV/AIDS who died with TB) was also predominantly male, with a lower age range (20-29 years), and had a heavy history of alcohol abuse, intravenous drug use, and gay sex, contributing to diagnostic delays and death attributable to underlying immunodeficiency.
  • The lack of isoniazid (INH) prophylaxis was a significant factor in TB mortality among patients with HIV/AIDS.
  • TB mortality in non-HIV/AIDS patients was associated with delay in medical attention and heavy alcohol use.
  • In contrast, TB mortality in HIV/AIDS patients was linked to diagnostic delays, lack of INH prophylaxis, and the degree of immunosuppression.
  • Early identification of cases in the general population and a higher index of suspicion among patients with HIV/AIDS are crucial for reducing TB mortality.

Statistics:

  • 70% of patients in Group A consulted only after one month of symptoms, at which point they already had severe and often disseminated disease.
  • Over 50% of patients in Group A died within 15 days of initiation of therapy.
  • 80% of patients in Group C had skipped medical attention until the late stages of the disease.

Sources:

  • Abstract submitted by C.A. Mosca, S. Rossi, J. Macias, R. Masini, P.J. Gonzalez-Montaner, and L.J. Gonzalez-Montaner to the 1994 International Conference of the American Lung Association and the American Thoracic Society, held May 21-25, 1994, in Boston, Massachusetts.